DiNAQOR is a genetic medicine platform company pioneering early-stage drug development and manufacturing to advance promising gene therapies to the clinic. Our patent-protected, industry leading platform is designed to overcome the challenges and limitations of advanced gene therapy development by using proprietary engineered heart tissue technology (EHT), a novel Loco-Regional Perfusion system (LRP) and a fully integrated manufacturing solution. Our company is headquartered in the Greater Zurich Area, Switzerland, with additional presence in Laguna Hills, California and Hamburg, Germany.
View Top Employees from DiNAQORWebsite | http://www.dinaqor.com/ |
Employees | 38 (38 on RocketReach) |
Founded | 2019 |
Address | Wagistrasse 25, Schlieren, Zurich 8952, CH |
Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
Industry | Biotechnology Research, Manufacturing General, Manufacturing |
SIC | SIC Code 80 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular DiNAQOR employee's phone or email?
Hanns-Eberhard Erle is the Chief Product Officer and Head of Technical Operations; Co-Founder of DiNAQOR.
38 people are employed at DiNAQOR.
DiNAQOR is based in Schlieren, Zurich.
The NAICS codes for DiNAQOR are [325, 3254, 32].
The SIC codes for DiNAQOR are [80, 28, 283].